title: Effect of Dexmedetomidine in Preventing Postoperative Side Effects for Laparoscopic Surgery: A Meta-Analysis of Randomized Controlled Trials and Trial Sequential Analysis (PRISMA).
abstract: Dexmedetomidine (DEX) has been used extensively for patients during surgery. Some studies found that DEX could reduce the incidence of postoperative side effects in laparoscopic surgical patients. However, no firm conclusions were made about it.The authors searched for randomized controlled trials (RCTs) in PubMed, EMBASE, and the Cochrane Central Register of Controlled Trials testing DEX administrated in laparoscopic surgical patients and reporting on postoperative nausea, vomiting, shivering, heart rate, mean arterial pressure (MAP), or extubation time after surgery or within 1 hour in postoperative care unit. Trial sequential analysis (TSA) was used for RCTs comparing DEX with placebo or no treatment in laparoscopic surgery patients. A protocol for this meta-analysis has been registered on PROSPERO (http://www.crd.york.ac.uk/prospero) and the registration number is CRD42015020226.Fifteen studies (899 patients) were included. DEX could significantly reduce the incidence of postoperative nausea (risk ratio [RR] and 95% confidence interval [CI], 0.43 [0.28, 0.66], P < 0.0001), vomiting (RR and 95% CI, 0.36 [0.18, 0.72], P = 0.004), shivering (RR and 95% CI, 0.19 [0.11, 0.35], P < 0.00001), rescue antiemetic (RR and 95% CI, 0.18 [0.07, 0.47], P = 0.0006), and increase the incidence of dry mouth (RR and 95% CI, 7.40 [2.07, 26.48], P = 0.002) comparing with the control group. In addition, firm conclusions can be made on the results of postoperative nausea according to the TSA. Meta-analysis showed that DEX group had a significantly lower heart rate (mean difference [MD] and 95% CI, -14.21 [-18.85, -9.57], P < 0.00001) and MAP (MD and 95% CI, -12.35 [-15.28, -9.42], P < 0.00001) than the control group, and firm conclusions can be made according to the TSA. No significance was observed on extubation time between 2 groups (MD and 95% CI, 0.70 [-0.89, 2.28], P = 0.39).The results from this meta-analysis indicated that perioperative DEX decreased postoperative nausea and shivering in laparoscopic surgical patients. However, common adverse effects were lower heart rate and MAP. Firm conclusions cannot be made on postoperative shivering, rescue antiemetic, and dry mouth until more RCTs were included.
authors.affiliation: From the Department of Orthopedics (GW, LCZ, SL, YUC, YAC, LHZ, PT), Chinese PLA General Hospital; and Beijing BOE Display Technology Co. Ltd. (RW), BDA, Beijing, P.R. China.
authors.forename: Guoqi
authors.initials: G
authors.lastname: Wang
authors.forename: Licheng
authors.initials: L
authors.lastname: Zhang
authors.forename: Shenghan
authors.initials: S
authors.lastname: Lou
authors.forename: Yuxiang
authors.initials: Y
authors.lastname: Chen
authors.forename: Yanxiang
authors.initials: Y
authors.lastname: Cao
authors.forename: Ruirui
authors.initials: R
authors.lastname: Wang
authors.forename: Lihai
authors.initials: L
authors.lastname: Zhang
authors.forename: Peifu
authors.initials: P
authors.lastname: Tang
mesh_terms: D058647:Adrenergic alpha-2 Receptor Agonists / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects; D020927:Dexmedetomidine / Q000627:therapeutic use*; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D010535:Laparoscopy / Q000009:adverse effects*; D020250:Postoperative Nausea and Vomiting / Q000209:etiology / Q000517:prevention & control*; D016032:Randomized Controlled Trials as Topic; D012768:Shivering / Q000187:drug effects
chemical_list: D058647:Adrenergic alpha-2 Receptor Agonists; D020927:Dexmedetomidine